Feb 23, 2026 08:00AM
Nov 6, 2025 07:02AM
Nov 14, 2024 04:05PM
Aug 13, 2024 04:05PM
Aug 9, 2024 04:05PM
Jun 7, 2024 07:52AM
May 16, 2024 08:30AM Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
May 16, 2024 08:30AM
May 15, 2024 08:30AM
Mar 25, 2024 08:30AM
Mar 18, 2024 04:05PM
Jan 4, 2024 08:31AM
Jan 4, 2024 08:30AM
Jan 2, 2024 08:30AM Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
Jan 2, 2024 08:30AM
Nov 13, 2023 04:05PM
Aug 14, 2023 04:01PM
Aug 10, 2023 04:15PM
Jul 27, 2023 08:30AM
Jul 25, 2023 08:31AM
Jul 25, 2023 08:30AM Avenue Therapeutics Announces Agreement with the FDA on the Study Design and Analysis Approach of the Phase 3 Safety Study for IV Tramadol
May 15, 2023 04:01PM
May 12, 2023 08:30AM
Apr 18, 2023 06:54AM
Apr 17, 2023 04:02PM
Apr 17, 2023 04:01PM
Mar 30, 2023 04:10PM
Mar 30, 2023 04:01PM Avenue Therapeutics Reports Full Year 2022 Financial Results and Recent Corporate Highlights
Mar 10, 2023 07:12AM
Mar 10, 2023 06:00AM
Mar 8, 2023 04:04PM
Mar 8, 2023 04:01PM
Mar 2, 2023 08:01AM
Mar 2, 2023 08:00AM
Nov 10, 2022 04:10PM Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Oct 3, 2022 08:00AM
Sep 22, 2022 05:46PM
Sep 22, 2022 04:25PM
Sep 22, 2022 04:25PM
Mar 31, 2022 07:34AM
Mar 31, 2022 07:30AM
Mar 31, 2022 07:30AM Abeona Therapeutics Announces Strategy Update and 2021 Financial Results
Feb 16, 2022 09:20AM
Feb 16, 2022 05:54AM
Feb 15, 2022 10:00PM
Feb 15, 2022 10:00PM
Feb 15, 2022 07:06AM
Feb 15, 2022 07:05AM
Feb 15, 2022 07:05AM Avenue Therapeutics Stock Trading Halted Today
Dec 15, 2021 12:00PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All